(Q51484788)
Statements
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone (English)
1 reference
Bernard Charbonnel
1 reference
Avraham Karasik
1 reference
Ji Liu
1 reference
Mei Wu
1 reference
Gary Meininger
1 reference
Sitagliptin Study 020 Group
1 reference
1 December 2006
1 reference
29
1 reference
12
1 reference
2638-2643
1 reference